KIDS NASDAQ
OrthoPediatrics Corp.
1W: +9.0%
1M: +6.5%
3M: +21.1%
YTD: +36.8%
1Y: +40.8%
3Y: -6.2%
5Y: -60.7%
$23.82
-0.20 (-0.83%)
After Hours: $24.45 (+0.62, +2.62%)
Weekly Expected Move ±5.4%
$22
$23
$24
$26
$27
Credit Risk of going bust: lower than 64% of companies Debt: 12.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.30 (down 99%), OrthoPediatrics Corp. would be worth roughly what it owes.
Total debt $91.6M against a stock market value of $627.2M.
Distance to default 6.78 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $45.9M (short-term plus half of long-term), stock volatility 41.8%; Altman Z 2.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.30 (down 99%), OrthoPediatrics Corp. would be worth roughly what it owes.
Total debt $91.6M against a stock market value of $627.2M.
Distance to default 6.78 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $45.9M (short-term plus half of long-term), stock volatility 41.8%; Altman Z 2.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
#74
of 256
Medical - Devices
Technical Signal Map
40 Bullish
6 Neutral
29 Bearish
KIDS
$640M
OrthoPediatrics Corp.
BULLISH
+91
GNNDY
$2.4B
GN Store Nord A/S
BULLISH
+100
CBLL
$1.0B
CeriBell, Inc.
BULLISH
+91
BVS
$1.0B
Bioventus Inc.
BULLISH
+91
CTKB
$730M
Cytek Biosciences, Inc.
BULLISH
+91
RCEL
$390M
Avita Medical Inc.
BULLISH
+91
QSI
$280M
Quantum-Si incorporated
BULLISH
+91
IRTC
$4.0B
iRhythm Technologies, Inc.
BULLISH
+84
TNDM
$1.2B
Tandem Diabetes Care, Inc.
BULLISH
+84
LMRI
$1.1B
Lumexa Imaging Holdings, Inc. Common Stock
BULLISH
+84
AVHHL
$360M
AVITA Medical, Inc.
BULLISH
+82
ENOV
$1.2B
Enovis Corporation
BULLISH
+75
IOBCF
$550M
Ion Beam Applications S.A.
BULLISH
+75
CV
$370M
CapsoVision, Inc.
BULLISH
+75
INFU
$280M
InfuSystem Holdings, Inc.
BULLISH
+74
PACB
$660M
Pacific Biosciences of California, Inc.
BULLISH
+69
GNGBY
$7.3B
Getinge AB (publ)
BULLISH
+66
SIBN
$960M
SI-BONE, Inc.
BULLISH
+66
LIVN
$4.4B
LivaNova PLC
BULLISH
+59
PRCT
$1.1B
PROCEPT BioRobotics Corporation
BULLISH
+59
BBNX
$860M
Beta Bionics, Inc.
BULLISH
+59
TCMD
$540M
Tactile Systems Technology, Inc.
BULLISH
+59
HAE
$5.4B
Haemonetics Corporation
BULLISH
+58
AMBBY
$3.2B
Ambu A/S
BULLISH
+53
DRWKF
$2.3B
Drägerwerk AG & Co. KGaA
BULLISH
+53
VTRLY
$1.4B
Vitrolife AB (publ)
BULLISH
+53
TMCI
$280M
Treace Medical Concepts, Inc.
BULLISH
+52
EKTAY
$2.2B
Elekta AB (publ)
BULLISH
+44
CNMD
$1.5B
CONMED Corporation
BULLISH
+41
ESTA
$1.9B
Establishment Labs Holdings Inc.
BULLISH
+35
CHEOY
$6.7B
Cochlear Limited
BULLISH
+34
SGHT
$500M
Sight Sciences, Inc.
BULLISH
+34
AORT
$1.1B
Artivion, Inc.
BULLISH
+31
INSP
$2.1B
Inspire Medical Systems, Inc.
LEAN BULL
+24
BIO
$9.9B
Bio-Rad Laboratories, Inc.
LEAN BULL
+18
PMI
$730M
Picard Medical, Inc.
LEAN BULL
+17
CERS
$470M
Cerus Corporation
LEAN BULL
+17
AHCO
$820M
AdaptHealth Corp.
LEAN BULL
+16
NEOG
$2.7B
Neogen Corporation
LEAN BULL
+10
ATEC
$1.7B
Alphatec Holdings, Inc.
LEAN BULL
+10
BRKR
$8.8B
Bruker Corporation
NEUTRAL
+8
ITGR
$4.3B
Integer Holdings Corporation
NEUTRAL
+6
VREX
$780M
Varex Imaging Corporation
NEUTRAL
+2
CSSPF
$380M
NIOX Group Plc
NEUTRAL
+2
OFIX
$400M
Orthofix Medical Inc.
NEUTRAL
0
AXGN
$2.2B
AxoGen, Inc.
NEUTRAL
-9
OSSFF
$1.9B
Embla Medical hf.
LEAN BEAR
-12
STSEY
$1.7B
Stratec SE
LEAN BEAR
-12
MDRSF
$1.4B
Medartis Holding AG
LEAN BEAR
-20
CLVSF
$330M
CellaVision AB (publ)
LEAN BEAR
-25
UFPT
$2.3B
UFP Technologies, Inc.
LEAN BEAR
-27
IMPZY
$230M
Implanet S.A.
BEARISH
-34
NPCE
$440M
NeuroPace, Inc.
BEARISH
-42
NHNKY
$3.1B
Nihon Kohden Corporation
BEARISH
-43
INMD
$800M
InMode Ltd.
BEARISH
-53
MTLZF
$680M
Metall Zug AG
BEARISH
-66
ELMD
$220M
Electromed, Inc.
BEARISH
-66
IRMD
$1.1B
IRadimed Corporation
BEARISH
-68
BFLY
$1.8B
Butterfly Network, Inc.
BEARISH
-75
NVCR
$1.7B
Novocure Ltd
BEARISH
-75
CSBTF
$950M
Kuros Biosciences AG
BEARISH
-78
IART
$930M
Integra LifeSciences Holdings Corporation
BEARISH
-78
XVIPY
$690M
Xvivo Perfusion AB (publ)
BEARISH
-82
DCTH
$500M
Delcath Systems, Inc.
BEARISH
-84
TLSI
$220M
TriSalus Life Sciences, Inc.
BEARISH
-84
ELEAF
$1.4B
EL.En. S.p.A.
BEARISH
-87
AVR
$570M
Anteris Technologies Global Corp.
BEARISH
-87
SENS
$400M
Senseonics Holdings, Inc.
BEARISH
-87
TMDX
$2.5B
TransMedics Group, Inc.
BEARISH
-100
FDMDF
$1.6B
4DMedical Limited
BEARISH
-100
MCRPF
$1.1B
MicroPort Scientific Corp.
BEARISH
-100
LFTSF
$1.0B
LifeTech Scientific Corporation
BEARISH
-100
SSII
$450M
SS Innovations International, Inc.
BEARISH
-100
CALZF
$430M
PolyNovo Limited
BEARISH
-100
CLPT
$280M
ClearPoint Neuro, Inc.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics Corp. | $640M | -14.3 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | BULLISH | 40.8 |
| GNNDY GN Store Nord A/S | $2.4B | -29.9 | -5.4 | 1.6 | -1.0 | -25.4 | 4 | BULLISH | -7.2 |
| CBLL CeriBell, Inc. | $1.0B | -15.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | BULLISH | 108.9 |
| BVS Bioventus Inc. | $1.0B | 18.1 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | BULLISH | 111.5 |
| CTKB Cytek Biosciences, Inc. | $730M | -9.6 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 41.6 |
| RCEL Avita Medical Inc. | $390M | -11.0 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 277.6 |
| QSI Quantum-Si incorporated | $280M | -3.5 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | -33.6 |
| IRTC iRhythm Technologies, Inc. | $4.0B | -287.0 | -9.6 | -3.4 | -0.2 | 25.6 | 6 | BULLISH | -33.1 |
| TNDM Tandem Diabetes Care, Inc. | $1.2B | -20.6 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BULLISH | 28.9 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $1.1B | -31.0 | -3.9 | 0.1 | 1.0 | — | 3 | BULLISH | — |
| AVHHL AVITA Medical, Inc. | $360M | -11.0 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 149.1 |
| ENOV Enovis Corporation | $1.2B | -1.1 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BULLISH | -35.1 |
| IOBCF Ion Beam Applications S.A. | $550M | 19.7 | 20.6 | 14.0 | 2.9 | 7.0 | 5 | BULLISH | 36.7 |
| CV CapsoVision, Inc. | $370M | -10.7 | -226.6 | -73.0 | -205.4 | — | 2 | BULLISH | 40.3 |
| INFU InfuSystem Holdings, Inc. | $280M | 33.5 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 37.3 |
| PACB Pacific Biosciences of California, Inc. | $660M | -5.8 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 15.4 |
| GNGBY Getinge AB (publ) | $7.3B | 25.9 | 9.1 | 8.1 | 8.5 | -3.9 | 7 | BULLISH | 13.2 |
| SIBN SI-BONE, Inc. | $960M | -63.3 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BULLISH | 38.1 |
| LIVN LivaNova PLC | $4.4B | 23.3 | 15.4 | 30.2 | 27.8 | 12.4 | 8 | BULLISH | 48.1 |
| PRCT PROCEPT BioRobotics Corporation | $1.1B | -10.2 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BULLISH | -42.7 |
| BBNX Beta Bionics, Inc. | $860M | -13.0 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | BULLISH | 2.5 |
| TCMD Tactile Systems Technology, Inc. | $540M | 21.4 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BULLISH | 56.5 |
| HAE Haemonetics Corporation | $5.4B | 58.5 | 11.2 | 10.1 | 9.7 | 0.4 | 8 | BULLISH | 132.2 |
| AMBBY Ambu A/S | $3.2B | 41.6 | 8.5 | 9.0 | 9.5 | -411.9 | 6 | BULLISH | -28.5 |
| DRWKF Drägerwerk AG & Co. KGaA | $2.3B | 11.2 | 11.0 | 9.8 | 3.5 | 6.5 | 9 | BULLISH | 36.8 |
| VTRLY Vitrolife AB (publ) | $1.4B | -3.1 | -46.2 | -41.3 | 14.3 | -2.0 | 5 | BULLISH | -33.7 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.9 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BULLISH | -34.9 |
| EKTAY Elekta AB (publ) | $2.2B | -60.9 | -4.4 | -49.1 | 7.5 | -7.8 | 4 | BULLISH | 8.0 |
| CNMD CONMED Corporation | $1.5B | 25.3 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BULLISH | -1.2 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -51.5 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BULLISH | 32.6 |
| CHEOY Cochlear Limited | $6.7B | 62.1 | 7.8 | 11.6 | -1.2 | -1.2 | 6 | BULLISH | -47.8 |
| SGHT Sight Sciences, Inc. | $500M | -16.1 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | BULLISH | 73.1 |
| AORT Artivion, Inc. | $1.1B | -386.5 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | BULLISH | -47.0 |
| INSP Inspire Medical Systems, Inc. | $2.1B | 15.2 | 18.0 | 19.7 | 0.2 | 4.3 | 8 | LEAN BULL | -11.4 |
| BIO Bio-Rad Laboratories, Inc. | $9.9B | 45.6 | 3.1 | 2.2 | 57.1 | 1.4 | 7 | LEAN BULL | 10.1 |
| PMI Picard Medical, Inc. | $730M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | LEAN BULL | -49.1 |
| CERS Cerus Corporation | $470M | -67.3 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | LEAN BULL | 57.0 |
| AHCO AdaptHealth Corp. | $820M | -3.5 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | LEAN BULL | -35.8 |
| NEOG Neogen Corporation | $2.7B | -49.3 | -2.7 | -0.2 | -5.3 | -0.3 | 7 | LEAN BULL | 101.2 |
| ATEC Alphatec Holdings, Inc. | $1.7B | -15.2 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | LEAN BULL | -31.4 |
| BRKR Bruker Corporation | $8.8B | -86.2 | -3.4 | 3.0 | -6.2 | 1.6 | 6 | NEUTRAL | 46.8 |
| ITGR Integer Holdings Corporation | $4.3B | 34.3 | 7.5 | 5.4 | 5.1 | 2.6 | 7 | NEUTRAL | 71.3 |
| VREX Varex Imaging Corporation | $780M | 35.1 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | NEUTRAL | 55.0 |
| CSSPF NIOX Group Plc | $380M | 41.3 | 10.8 | 13.0 | 24.6 | 3.5 | 7 | NEUTRAL | -2.3 |
| OFIX Orthofix Medical Inc. | $400M | -6.4 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | NEUTRAL | -38.6 |
| AXGN AxoGen, Inc. | $2.2B | -56.1 | -18.2 | -5.6 | -2.2 | 23.6 | 4 | NEUTRAL | 110.6 |
| OSSFF Embla Medical hf. | $1.9B | 18.0 | 10.4 | 7.7 | 10.5 | 9.9 | 7 | LEAN BEAR | -5.6 |
| STSEY Stratec SE | $1.7B | -575.0 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | LEAN BEAR | -17.8 |
| MDRSF Medartis Holding AG | $1.4B | 78.9 | 5.5 | 0.7 | 3.2 | 29.6 | 6 | LEAN BEAR | 72.5 |
| CLVSF CellaVision AB (publ) | $330M | 31.6 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| UFPT UFP Technologies, Inc. | $2.3B | 31.4 | 17.1 | 13.3 | 12.0 | 7.3 | 7 | LEAN BEAR | 45.5 |
| IMPZY Implanet S.A. | $230M | -5.1 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| NPCE NeuroPace, Inc. | $440M | -23.0 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | BEARISH | 23.1 |
| NHNKY Nihon Kohden Corporation | $3.1B | 19.1 | 7.8 | 7.9 | -1.6 | 2.6 | 9 | BEARISH | -22.6 |
| INMD InMode Ltd. | $800M | 10.9 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -11.4 |
| MTLZF Metall Zug AG | $680M | -34.8 | -2.8 | -1.4 | -5.6 | -0.3 | 6 | BEARISH | 0.0 |
| ELMD Electromed, Inc. | $220M | 19.3 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 8.1 |
| IRMD IRadimed Corporation | $1.1B | 46.0 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 9.4 |
| BFLY Butterfly Network, Inc. | $1.8B | -25.4 | -35.5 | -74.8 | -39.6 | 28.1 | 4 | BEARISH | 199.6 |
| NVCR Novocure Ltd | $1.7B | -11.2 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 3.5 |
| CSBTF Kuros Biosciences AG | $950M | 109.9 | 9.6 | 9.2 | 4.8 | 29.1 | 4 | BEARISH | -43.1 |
| IART Integra LifeSciences Holdings Corporation | $930M | 70.5 | 1.2 | 13.4 | 3.6 | 0.8 | 6 | BEARISH | -23.8 |
| XVIPY Xvivo Perfusion AB (publ) | $690M | 49.4 | 5.9 | 4.6 | 17.7 | 17.5 | 6 | BEARISH | — |
| DCTH Delcath Systems, Inc. | $500M | 1344.2 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 39.8 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -2.9 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -29.4 |
| ELEAF EL.En. S.p.A. | $1.4B | 13.7 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 37.9 |
| AVR Anteris Technologies Global Corp. | $570M | -2.2 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 3.4 |
| SENS Senseonics Holdings, Inc. | $400M | -3.7 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BEARISH | 1.8 |
| TMDX TransMedics Group, Inc. | $2.5B | 15.8 | 36.3 | 18.7 | 7.7 | 25.8 | 3 | BEARISH | -45.2 |
| FDMDF 4DMedical Limited | $1.6B | -9.2 | -174.5 | 43.4 | -1194.8 | 20.5 | 3 | BEARISH | 132.8 |
| MCRPF MicroPort Scientific Corp. | $1.1B | 31.2 | 6.1 | -1.7 | 21.3 | -3.5 | 5 | BEARISH | -64.8 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 103.0 | 7.3 | 6.9 | -5.7 | 103.7 | 4 | BEARISH | -14.3 |
| SSII SS Innovations International, Inc. | $450M | -39.0 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -74.4 |
| CALZF PolyNovo Limited | $430M | 82.1 | 8.4 | 9.3 | 10.0 | 12.8 | 7 | BEARISH | -34.2 |
| CLPT ClearPoint Neuro, Inc. | $280M | -8.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -64.2 |
| KIDS OrthoPediatrics Corp. | $640M | -14.3 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | BULLISH | 40.8 |
| AONC American Oncology Network, Inc. | $640M | -29.7 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | BULLISH | 133.3 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -32.9 |
| SOPH SOPHiA GENETICS S.A. | $630M | -6.7 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | LEAN BULL | 82.5 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| STLN Starling Oncology, Inc. | $670M | — | — | — | — | — | — | BEARISH | — |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.3 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -24.4 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 8.8 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.0 | -214.6 | 174.4 | — | — | 1 | BEARISH | 207.7 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.4 | -845.0 | 24.6 | — | — | 2 | BEARISH | 32.9 |
| DSGN Design Therapeutics, Inc. | $640M | -9.1 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 81.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 5.2 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 18.9 |
| HELP Helus Pharma Inc. | $630M | -2.6 | -56.3 | -143.0 | — | — | 2 | BEARISH | — |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -54.5 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $660M | 10.8 | 4.1 | 12.2 | 8.2 | -18.2 | 6 | BEARISH | -43.0 |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -26.2 |
| CRWRF Craneware plc | $620M | 25.9 | 6.0 | 6.8 | 9.7 | 4.2 | 7 | BEARISH | -43.9 |
| ATTO Attovia Therapeutics, Inc. | $630M | -15.3 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 226.6 |
| NNCSF Nanosonics Limited | $620M | 53.0 | 8.3 | 15.6 | 8.1 | 2.4 | 4 | BEARISH | -39.9 |
| KIDS OrthoPediatrics Corp. | $640M | -14.3 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | BULLISH | 40.8 |
| CAI Caris Life Sciences, Inc. | $9.1B | 91.5 | 20.1 | 61.1 | -0.2 | 445.5 | 7 | BULLISH | 2.5 |
| RGEDF Chemical Works of Gedeon Richter Plc | $7.4B | 10.7 | 16.2 | 24.3 | 15.9 | 1.8 | 5 | BULLISH | 33.2 |
| ALKS Alkermes plc | $7.3B | 110.1 | 3.9 | 2.9 | 0.1 | 10.8 | 4 | BULLISH | 47.9 |
| AMRX Amneal Pharmaceuticals, Inc. | $6.5B | 43.0 | -395.8 | 16.0 | 7.2 | 9.3 | 8 | BULLISH | 101.7 |
| MANE Veradermics, Incorporated | $5.8B | — | — | — | — | — | — | BULLISH | — |
| TFX Teleflex Incorporated | $5.8B | -5.9 | -28.8 | 1.3 | 17.9 | -14.5 | 5 | BULLISH | 3.8 |
| MMSI Merit Medical Systems, Inc. | $5.6B | 38.2 | 9.2 | 7.3 | 9.3 | 10.2 | 9 | BULLISH | 13.0 |
| CON Concentra Group Holdings Parent, Inc. | $5.0B | 25.7 | 48.5 | 66.4 | 10.8 | 14.0 | 9 | BULLISH | 96.2 |
| LFST LifeStance Health Group, Inc. | $4.9B | 101.0 | 3.4 | 4.1 | 5.4 | 20.4 | 7 | BULLISH | 154.1 |
| ATRC AtriCure, Inc. | $3.0B | 289.6 | 2.2 | 2.9 | 5.8 | 13.9 | 8 | BULLISH | 63.4 |
| GNNDY GN Store Nord A/S | $2.4B | -29.9 | -5.4 | 1.6 | -1.0 | -25.4 | 4 | BULLISH | -7.2 |
| VCEL Vericel Corporation | $2.2B | 90.6 | 7.2 | 5.9 | 2.8 | 23.0 | 7 | BULLISH | 19.6 |
| LKFT Lakefront Biotherapeutics N.V. | $2.1B | — | — | — | — | — | — | BULLISH | — |
| AMN AMN Healthcare Services, Inc. | $1.9B | 17.2 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 145.7 |
| HCSG Healthcare Services Group, Inc. | $1.7B | 16.0 | 20.4 | 27.0 | 5.2 | 4.0 | 7 | BULLISH | 35.0 |
| ARDT Ardent Health Inc. | $1.7B | 21.6 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BULLISH | -17.6 |
| CERT Certara, Inc. | $1.6B | -24.5 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -15.1 |
| MRCHF H.U. Group Holdings, Inc. | $1.3B | 22.0 | 7.2 | 3.3 | 2.5 | 1.8 | 9 | BULLISH | -7.4 |
| LTGHY Life Healthcare Group Holdings Limited | $1.1B | 2.7 | 68.5 | 10.7 | 6.2 | -3.0 | 4 | BULLISH | 14.2 |
| HSTM HealthStream, Inc. | $1.1B | 47.8 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 31.7 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 28.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -15.8 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 41.9 |
| MOBI Mobia Medical, Inc. Common Stock | $350M | — | — | — | — | — | — | BULLISH | — |
| HNGE Hinge Health, Inc. | $9.0B | 84.6 | 30.4 | -235.0 | 20.5 | 417.7 | 7 | BULLISH | 125.4 |
| HQY HealthEquity, Inc. | $8.6B | 36.3 | 11.4 | 9.9 | 18.7 | 7.3 | 8 | BULLISH | 7.7 |
| PACS PACS Group, Inc. | $7.5B | 28.0 | 28.1 | 6.9 | 5.3 | 15.2 | 8 | BULLISH | 282.6 |
| SSMXY Sysmex Corporation | $7.4B | 30.7 | 8.5 | 10.0 | 6.7 | 6.2 | 5 | BULLISH | 4.1 |
| DOCS Doximity, Inc. | $6.0B | 37.2 | 17.2 | 60.2 | 15.5 | 11.2 | 6 | BULLISH | -50.1 |
| WAY Waystar Holding Corp. | $5.5B | 38.9 | 3.8 | 3.8 | 12.8 | 19.2 | 7 | BULLISH | -24.6 |
| HKMPY Hikma Pharmaceuticals PLC | $4.6B | 12.7 | 15.3 | 12.1 | 12.9 | 6.1 | 7 | BULLISH | -3.4 |
| ARQT Arcutis Biotherapeutics, Inc. | $3.9B | 143.7 | 15.9 | 34.7 | 11.6 | 76.1 | 7 | BULLISH | 58.4 |
| ACHC Acadia Healthcare Company, Inc. | $2.9B | -2.4 | -44.5 | 6.1 | 1.3 | 4.3 | 4 | BULLISH | 33.4 |
| BVNRY Bavarian Nordic A/S | $2.9B | 13.0 | 12.3 | 7.1 | 36.0 | -5.8 | 7 | BULLISH | -0.2 |
| BHC Bausch Health Companies Inc. | $2.4B | -2.1 | 86.8 | 12.2 | 9.0 | 10.5 | 5 | BULLISH | -0.3 |
| MD Pediatrix Medical Group, Inc. | $2.4B | 13.7 | 20.4 | 15.9 | 8.2 | 0.5 | 7 | BULLISH | 69.1 |
| FTRE Fortrea Holdings Inc. | $2.2B | -26.2 | -15.3 | 0.6 | -1.9 | -2.1 | 6 | BULLISH | 120.7 |
| PGNY Progyny, Inc. | $2.2B | 28.5 | 16.2 | 30.2 | 8.0 | 5.5 | 7 | BULLISH | 44.3 |
| AGIO Agios Pharmaceuticals, Inc. | $2.2B | -5.4 | -34.3 | -82.5 | -225.1 | 140.6 | 4 | BULLISH | -12.4 |
| PRGO Perrigo Company plc | $2.2B | -1.3 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | BULLISH | -24.8 |
| BOEUF Bonesupport Holding AB (publ) | $2.1B | 78.2 | 29.2 | 54.1 | 22.6 | 23.4 | 8 | BULLISH | 36.7 |
| GDRX GoodRx Holdings, Inc. | $1.2B | 65.6 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BULLISH | -7.8 |
| CBLL CeriBell, Inc. | $1.0B | -15.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | BULLISH | 108.9 |
| BVS Bioventus Inc. | $1.0B | 18.1 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | BULLISH | 111.5 |
| CTKB Cytek Biosciences, Inc. | $730M | -9.6 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 41.6 |
| AONC American Oncology Network, Inc. | $640M | -29.7 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | BULLISH | 133.3 |
| EVH Evolent Health, Inc. | $540M | -1.0 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BULLISH | -39.6 |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 33.6 |
| RCEL Avita Medical Inc. | $390M | -11.0 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 277.6 |
| QSI Quantum-Si incorporated | $280M | -3.5 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | -33.6 |
| SGRY Surgery Partners, Inc. | $2.1B | -33.7 | -5.2 | 5.9 | -1.8 | 4.0 | 5 | BULLISH | 5.8 |
| OMCL Omnicell, Inc. | $1.7B | 42.8 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | BULLISH | 19.7 |
| LWSCF Sienna Senior Living Inc. | $1.6B | 38.9 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | BULLISH | 7.9 |
| PHR Phreesia, Inc. | $790M | 71.5 | 3.1 | 16.7 | 1.5 | 12.9 | 4 | BULLISH | -46.3 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | 5.2 |
| BLCO Bausch + Lomb Corporation | $6.2B | -36.9 | -2.7 | 2.8 | -1.0 | 8.8 | 5 | BULLISH | 11.2 |
| IRTC iRhythm Technologies, Inc. | $4.0B | -287.0 | -9.6 | -3.4 | -0.2 | 25.6 | 6 | BULLISH | -33.1 |
| LEGN Legend Biotech Corporation | $3.6B | -42.9 | -8.1 | -8.2 | 8.6 | 59.5 | 4 | BULLISH | -35.6 |
| TNDM Tandem Diabetes Care, Inc. | $1.2B | -20.6 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BULLISH | 28.9 |
| STAA STAAR Surgical Company | $1.1B | 301.5 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | BULLISH | -13.8 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $1.1B | -31.0 | -3.9 | 0.1 | 1.0 | — | 3 | BULLISH | — |
| NRC NRC Health | $490M | 82.2 | 42.0 | 9.9 | -9.3 | -0.2 | 6 | BULLISH | 42.5 |
| AVHHL AVITA Medical, Inc. | $360M | -11.0 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 149.1 |
| VRDN Viridian Therapeutics, Inc. | $2.5B | -6.7 | -65.7 | 418.2 | -44760.2 | 23220.3 | 4 | BULLISH | 5.8 |
| GRRMF Gerresheimer AG | $1.2B | -2.8 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BULLISH | -27.1 |
| QDEL QuidelOrtho Corporation | $940M | -0.9 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BULLISH | -53.8 |
| TDVXF Dynavox Group AB (publ) | $900M | 27.8 | 39.7 | 17.2 | 12.8 | 8.8 | 8 | BULLISH | -22.7 |
| HTFL Heartflow, Inc. Common Stock | $4.9B | -41.1 | -42.3 | -39.8 | -24.6 | — | 2 | BULLISH | 42.9 |
| DSRLF DiaSorin S.p.A. | $4.4B | 25.1 | 14.2 | 8.9 | 14.0 | 46.3 | 5 | BULLISH | -2.4 |
| VCYT Veracyte, Inc. | $3.9B | 35.8 | 8.8 | 10.7 | 17.0 | 17.3 | 8 | BULLISH | 35.2 |
| PLSE Pulse Biosciences, Inc. | $3.8B | -44.9 | -78.5 | -1410.2 | -5681.3 | — | 3 | BULLISH | 202.6 |
| CZMWY Carl Zeiss Meditec AG | $3.5B | 21.1 | 5.6 | 4.8 | 9.8 | 22.1 | 7 | BULLISH | -28.0 |
| AVAH Aveanna Healthcare Holdings Inc. | $2.9B | 9.6 | 199.1 | 30.4 | 6.0 | 20.3 | 6 | BULLISH | 44.5 |
| SZUKF Suzuken Co., Ltd. | $2.4B | 10.9 | 9.3 | 8.6 | 0.5 | 5.0 | 4 | BULLISH | 18.9 |
| AUPH Aurinia Pharmaceuticals Inc. | $2.2B | 7.3 | 66.1 | 127.2 | 45.0 | 19.8 | 7 | BULLISH | 47.1 |
| BHVN Biohaven Ltd. | $2.1B | -3.3 | -799.5 | -1083.0 | — | — | 3 | BULLISH | -11.3 |
| SAEYY Redcare Pharmacy N.V. | $1.7B | -37.3 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -13.7 |
| KMTS Kestra Medical Technologies, Ltd. | $1.7B | -11.3 | -73.7 | -113.5 | -142.3 | 191.6 | 3 | BULLISH | 14.5 |
| AGL Agilon Health, Inc. | $1.5B | -5.9 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BULLISH | 266.8 |
| PNTG The Pennant Group, Inc. | $1.5B | 44.1 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | BULLISH | 71.9 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 68.0 |
| NWKHY Netcare Limited | $1.4B | 12.5 | 16.9 | 8.1 | 6.7 | 5.0 | 7 | BULLISH | 58.3 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 511.8 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | BULLISH | -0.4 |
| ENOV Enovis Corporation | $1.2B | -1.1 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BULLISH | -35.1 |
| TDOC Teladoc Health, Inc. | $1.1B | -6.4 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BULLISH | -27.3 |
| ARRJF Arjo AB (publ) | $920M | 25.3 | 4.6 | 4.4 | 2.0 | -2.0 | 6 | BULLISH | 3.1 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.8 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 69.9 |
| IOBCF Ion Beam Applications S.A. | $550M | 19.7 | 20.6 | 14.0 | 2.9 | 7.0 | 5 | BULLISH | 36.7 |
| VMD Viemed Healthcare, Inc. | $370M | 25.7 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 42.5 |
| CV CapsoVision, Inc. | $370M | -10.7 | -226.6 | -73.0 | -205.4 | — | 2 | BULLISH | 40.3 |
| INFU InfuSystem Holdings, Inc. | $280M | 33.5 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 37.3 |
| IDGXF Integrated Diagnostics Holdings plc | $340M | 10.4 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BULLISH | 10.8 |
| PACB Pacific Biosciences of California, Inc. | $660M | -5.8 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 15.4 |
| GNGBY Getinge AB (publ) | $7.3B | 25.9 | 9.1 | 8.1 | 8.5 | -3.9 | 7 | BULLISH | 13.2 |
| HLUBF H. Lundbeck A/S | $7.3B | 13.4 | 15.2 | 12.6 | 17.6 | 10.1 | 7 | BULLISH | 22.5 |
| CNVVY ConvaTec Group Plc | $6.3B | 50.6 | 7.6 | 10.2 | 4.4 | 5.5 | 5 | BULLISH | -0.4 |
| MAHLY MediPal Holdings Corporation | $4.1B | 15.1 | 7.5 | 8.7 | 1.4 | 5.9 | 7 | BULLISH | 23.9 |
| IRON Disc Medicine, Inc. | $2.9B | -12.1 | -39.1 | 1672.3 | — | — | 1 | BULLISH | -7.2 |
| NRIX Nurix Therapeutics, Inc. | $2.8B | 10.6 | 44.0 | -1896.6 | 81.7 | 738.8 | 8 | BULLISH | 145.5 |
| ZYME Zymeworks Inc. | $2.0B | -14.3 | -72.3 | -156.9 | -980.8 | -69.8 | 2 | BULLISH | 63.0 |
| XNCR Xencor, Inc. | $1.9B | -13.7 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 136.5 |
| TGLVY Top Glove Corporation Bhd. | $1.7B | 25.1 | 6.3 | 8.5 | 12.6 | 21.4 | 8 | BULLISH | 41.3 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.4 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.4 |
| SIBN SI-BONE, Inc. | $960M | -63.3 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BULLISH | 38.1 |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 172.8 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.5 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 98.5 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.3 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 115.3 |
| LVZPF Livzon Pharmaceutical Group Inc. | $6.1B | 16.0 | 11.5 | 16.4 | 15.3 | -14.4 | 4 | BULLISH | 0.0 |
| ORKA Oruka Therapeutics, Inc. | $5.3B | -38.6 | -18.2 | -50.3 | — | — | 4 | BULLISH | 232.9 |
| OPK OPKO Health, Inc. | $1.2B | -16.8 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | BULLISH | 7.2 |
| MYGN Myriad Genetics, Inc. | $560M | -5.3 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -25.2 |
| AZTA Azenta, Inc. | $1.6B | -14.3 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 14.8 |
| AHG Akso Health Group | $1.1B | -20.2 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -24.4 |
| KYMR Kymera Therapeutics, Inc. | $9.1B | -36.7 | -24.2 | -30.7 | -94.2 | 134.8 | 6 | BULLISH | 98.8 |
| OPHLY Ono Pharmaceutical Co., Ltd. | $7.4B | 15.2 | 9.5 | 11.3 | 20.8 | 3.3 | 9 | BULLISH | 32.7 |
| ERAS Erasca, Inc. | $5.0B | -15.8 | -78.2 | -87.5 | — | — | 2 | BULLISH | 578.3 |
| LIVN LivaNova PLC | $4.4B | 23.3 | 15.4 | 30.2 | 27.8 | 12.4 | 8 | BULLISH | 48.1 |
| SNPHY Santen Pharmaceutical Co., Ltd. | $3.6B | 14.7 | 13.6 | 14.9 | 10.4 | 0.9 | 8 | BULLISH | 10.7 |
| PRCT PROCEPT BioRobotics Corporation | $1.1B | -10.2 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BULLISH | -42.7 |
| BBNX Beta Bionics, Inc. | $860M | -13.0 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | BULLISH | 2.5 |
| PHAR Pharming Group N.V. | $710M | 81.8 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -19.6 |
| TCMD Tactile Systems Technology, Inc. | $540M | 21.4 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BULLISH | 56.5 |
| SI Shoulder Innovations, Inc. | $410M | -11.6 | -28.2 | -69.1 | -59.1 | — | 1 | BULLISH | 54.1 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -5.9 |
| MTHRY M3, Inc. | $8.2B | 27.5 | 12.1 | 16.9 | 10.1 | 17.7 | 7 | BULLISH | -16.9 |
| HAE Haemonetics Corporation | $5.4B | 58.5 | 11.2 | 10.1 | 9.7 | 0.4 | 8 | BULLISH | 132.2 |
| CDNA CareDx, Inc | $3.6B | 32.8 | 29.5 | -2.5 | 83.8 | 34.4 | 8 | BULLISH | 370.1 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -42.2 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -11.9 | -114.6 | 616.3 | — | — | 2 | BULLISH | 29.3 |
| ONTTF Oxford Nanopore Technologies plc | $2.7B | -18.0 | -25.6 | -36.2 | -41.1 | 14.4 | 4 | BULLISH | 41.4 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| ESAIY Eisai Co., Ltd. | $9.2B | 34.0 | 3.8 | 3.3 | 7.8 | 248.0 | 6 | BULLISH | 9.2 |
| ATR AptarGroup, Inc. | $8.1B | 22.6 | 13.6 | 10.1 | 8.5 | 8.9 | 6 | BULLISH | -2.8 |
| AKBLF ALK-Abelló A/S | $7.4B | 39.9 | 21.2 | 23.9 | 18.9 | 16.4 | 8 | BULLISH | 12.8 |
| OPCH Option Care Health, Inc. | $4.7B | 23.5 | 16.0 | 10.6 | 3.7 | 5.9 | 5 | BULLISH | 11.4 |
| AMBBY Ambu A/S | $3.2B | 41.6 | 8.5 | 9.0 | 9.5 | -411.9 | 6 | BULLISH | -28.5 |
| PRVA Privia Health Group, Inc. | $2.9B | 97.1 | 0.0 | 0.0 | 1.4 | 24.1 | 1 | BULLISH | -14.4 |
| ADMA ADMA Biologics, Inc. | $2.4B | 15.4 | 41.9 | 35.5 | 30.4 | 8.0 | 5 | BULLISH | -27.4 |
| DRWKF Drägerwerk AG & Co. KGaA | $2.3B | 11.2 | 11.0 | 9.8 | 3.5 | 6.5 | 9 | BULLISH | 36.8 |
| VTRLY Vitrolife AB (publ) | $1.4B | -3.1 | -46.2 | -41.3 | 14.3 | -2.0 | 5 | BULLISH | -33.7 |
| EMBC Embecta Corp. | $380M | 4.4 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | BULLISH | -51.3 |
| CASBF CanSino Biologics Inc. | $1.4B | 367.7 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.9 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BULLISH | -34.9 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BULLISH | — |
| SEPN Septerna Inc | $1.9B | -81.5 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 89.9 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.4 | -37.3 | -112.3 | — | — | 3 | BULLISH | 3.9 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.7 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | BULLISH | -4.7 |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -29.8 |
| VHIBF Vitalhub Corp. | $340M | 62.2 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | BULLISH | -28.2 |
| TCHBF Tecan Group AG | $3.5B | -26.5 | -9.7 | 2.8 | 2.9 | -4.2 | 6 | BULLISH | 45.2 |
| ASTH Astrana Health, Inc. | $1.9B | 44.5 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | BULLISH | 12.3 |
| MASS 908 Devices Inc. | $470M | -13.3 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 38.7 |
| GRAL GRAIL Inc. | $5.9B | -15.7 | -16.1 | -24.9 | -246.7 | 23.1 | 5 | BULLISH | 69.3 |
| EKTAY Elekta AB (publ) | $2.2B | -60.9 | -4.4 | -49.1 | 7.5 | -7.8 | 4 | BULLISH | 8.0 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -32.9 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $460M | 75.9 | 1.9 | -0.5 | -19.7 | 66.6 | 4 | BULLISH | -17.1 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.5 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 68.3 |
| BLLN BillionToOne, Inc. | $5.1B | 166.9 | 6.0 | 25.2 | 7.4 | — | 4 | BULLISH | — |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -52.2 |
| COLL Collegium Pharmaceutical, Inc. | $750M | 15.0 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | BULLISH | -34.7 |
| CARL Carlsmed, Inc. | $400M | -11.5 | -43.8 | -122.7 | -55.5 | — | 2 | BULLISH | 14.6 |
| SYRE Spyre Therapeutics, Inc. | $8.3B | -50.4 | -23.0 | 359.8 | — | — | 3 | BULLISH | 315.3 |
| LMAT LeMaitre Vascular, Inc. | $1.9B | 29.1 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | BULLISH | -5.1 |
| INNV Innovage Holding Corp. | $1.3B | -439.5 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | BULLISH | 77.6 |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 6.0 | 19.9 | 46.7 | 21.6 | 1081.8 | 8 | BULLISH | 0.0 |
| ICUI ICU Medical, Inc. | $4.2B | 136.5 | 1.4 | 2.7 | 3.5 | -9.0 | 6 | BULLISH | 36.4 |
| ADUS Addus HomeCare Corporation | $2.3B | 21.3 | 9.7 | 9.6 | 7.3 | 15.9 | 6 | BULLISH | 0.4 |
| IMCR Immunocore Holdings plc | $1.6B | -176.2 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -1.0 |
| CNMD CONMED Corporation | $1.5B | 25.3 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BULLISH | -1.2 |
| LQDA Liquidia Corporation | $3.8B | 29.0 | 131.8 | 391.9 | 43.5 | 2233.6 | 6 | BULLISH | 98.6 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.0 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 11.8 |
| GMRS GMR Solutions Inc. | $580M | — | — | — | — | — | — | BULLISH | — |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.3 | 5.6 | 7.4 | 11.3 | 2.2 | 6 | BULLISH | -39.1 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -51.5 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BULLISH | 32.6 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 63.5 |
| CHEOY Cochlear Limited | $6.7B | 62.1 | 7.8 | 11.6 | -1.2 | -1.2 | 6 | BULLISH | -47.8 |
| CHE Chemed Corporation | $6.7B | 25.4 | 27.1 | 23.2 | 10.1 | 3.3 | 6 | BULLISH | 18.1 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| SGHT Sight Sciences, Inc. | $500M | -16.1 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | BULLISH | 73.1 |
| LGND Ligand Pharmaceuticals Incorporated | $6.0B | 31.2 | 22.0 | 11.3 | 76.2 | 54.9 | 5 | BULLISH | 66.4 |
| APNHY Aspen Pharmacare Holdings Limited | $4.2B | 26.9 | 3.2 | 5.3 | 6.6 | -20.1 | 7 | BULLISH | 69.4 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.2 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 91.0 |
| CRON Cronos Group Inc. | $1.2B | 18.0 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 33.5 |
| HCM HUTCHMED (China) Limited | $2.6B | 149.4 | 46.6 | 11.0 | 5.7 | -11.8 | 6 | BULLISH | -5.1 |
| IOVA Iovance Biotherapeutics, Inc. | $6.4B | -20.1 | -40.4 | -49.1 | -47.6 | 34.5 | 6 | BULLISH | 529.2 |
| AORT Artivion, Inc. | $1.1B | -386.5 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | BULLISH | -47.0 |
| CYDY CytoDyn Inc. | $380M | -4.9 | 57.8 | 24.6 | — | 100.0 | 4 | BULLISH | -5.6 |
| SHC Sotera Health Company | $5.2B | 32.2 | 27.8 | 10.6 | 16.7 | 8.1 | 7 | LEAN BULL | 8.8 |
| SOPH SOPHiA GENETICS S.A. | $630M | -6.7 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | LEAN BULL | 82.5 |
| CYH Community Health Systems, Inc. | $410M | -1.2 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | LEAN BULL | -9.5 |
| TGTX TG Therapeutics, Inc. | $8.3B | 18.5 | 100.3 | 73.5 | 3.2 | 76.1 | 6 | LEAN BULL | 63.6 |
| SHTDF Sinopharm Group Co. Ltd. | $6.3B | 6.2 | 8.4 | 8.1 | 1.2 | -2.2 | 5 | LEAN BULL | -18.8 |
| MRVI Maravai LifeSciences Holdings, Inc. | $2.1B | -15.3 | -32.9 | 24.4 | -24.1 | -3.3 | 5 | LEAN BULL | 117.8 |
| XRAY DENTSPLY SIRONA Inc. | $1.9B | -3.4 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | LEAN BULL | -28.9 |
| COGZF Cogstate Limited | $410M | 34.6 | 22.4 | 37.3 | 22.4 | -14.8 | 3 | LEAN BULL | 44.9 |
| PTCHF PureTech Health plc | $390M | 157.1 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.2 | -24.4 | -231.4 | — | — | 3 | LEAN BULL | 30.4 |
| SDGCF Sundrug Co.,Ltd. | $3.3B | 13.5 | 11.4 | 10.6 | 3.7 | 4.9 | 6 | LEAN BULL | 0.0 |
| ARHCF Alfresa Holdings Corporation | $2.5B | 11.4 | 5.7 | 7.8 | 0.2 | 3.6 | 5 | LEAN BULL | 17.9 |
| INSP Inspire Medical Systems, Inc. | $2.1B | 15.2 | 18.0 | 19.7 | 0.2 | 4.3 | 8 | LEAN BULL | -11.4 |
| TSMRF Tsumura & Co. | $1.7B | 9.2 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.7 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 21.1 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 14.0 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | -7.4 |
| OSCR Oscar Health, Inc. | $8.0B | 18.4 | 34.3 | -9.6 | 7.4 | 42.8 | 7 | LEAN BULL | 58.5 |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | LEAN BULL | 24.8 |
| BIO Bio-Rad Laboratories, Inc. | $9.9B | 45.6 | 3.1 | 2.2 | 57.1 | 1.4 | 7 | LEAN BULL | 10.1 |
| KOD Kodiak Sciences Inc. | $5.5B | -21.7 | -368.4 | -630.1 | — | — | 1 | LEAN BULL | 423.7 |
| NVST Envista Holdings Corp | $3.8B | 40.2 | 3.1 | 3.2 | 7.4 | 11.9 | 7 | LEAN BULL | 17.0 |
| HUMDF Hua Medicine (Shanghai) Ltd. | $300M | -17.8 | -10.3 | -30.2 | -8.0 | 73.9 | 3 | LEAN BULL | -26.1 |
| PMI Picard Medical, Inc. | $730M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | LEAN BULL | -49.1 |
| CERS Cerus Corporation | $470M | -67.3 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | LEAN BULL | 57.0 |
| AHCO AdaptHealth Corp. | $820M | -3.5 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | LEAN BULL | -35.8 |
| PBH Prestige Consumer Healthcare Inc. | $2.3B | 13.2 | 9.1 | 5.5 | 11.0 | -1.4 | 4 | LEAN BULL | -23.0 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | LEAN BULL | -33.7 |
| SKHHY Sonic Healthcare Limited | $6.5B | 15.5 | 7.3 | 6.2 | 6.2 | 52.7 | 5 | LEAN BULL | -6.3 |
| ALBHF Alibaba Health Information Technology Limited | $6.3B | 19.9 | 11.2 | 20.8 | 3.8 | -36.2 | 3 | LEAN BULL | -50.2 |
| NEOG Neogen Corporation | $2.7B | -49.3 | -2.7 | -0.2 | -5.3 | -0.3 | 7 | LEAN BULL | 101.2 |
| ATEC Alphatec Holdings, Inc. | $1.7B | -15.2 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | LEAN BULL | -31.4 |
| IUSDF AS ONE Corporation | $1.0B | 19.2 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | LEAN BULL | -39.5 |
| MLAB Mesa Laboratories, Inc. | $720M | 150.7 | 2.7 | 4.4 | 4.7 | 3.0 | 8 | LEAN BULL | 65.4 |
| BRKR Bruker Corporation | $8.8B | -86.2 | -3.4 | 3.0 | -6.2 | 1.6 | 6 | NEUTRAL | 46.8 |
| MSMKF MatsukiyoCocokara & Co. | $5.8B | 18.0 | 11.1 | 12.6 | 5.1 | 5.7 | 8 | NEUTRAL | -16.3 |
| ZLAB Zai Lab Limited | $2.7B | -13.3 | -26.9 | -85.4 | -47.8 | 5.1 | 3 | NEUTRAL | -13.1 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| CSTL Castle Biosciences, Inc. | $1.0B | -52.0 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | NEUTRAL | 37.7 |
| KMDA Kamada Ltd. | $450M | 21.0 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | NEUTRAL | 15.9 |
| KYKOF Kyowa Kirin Co., Ltd. | $8.1B | 15.6 | 9.3 | 14.2 | 12.8 | 7.4 | 7 | NEUTRAL | -8.1 |
| ITGR Integer Holdings Corporation | $4.3B | 34.3 | 7.5 | 5.4 | 5.1 | 2.6 | 7 | NEUTRAL | 71.3 |
| PTGX Protagonist Therapeutics, Inc. | $9.0B | 115.5 | 11.0 | 84.1 | 76.3 | 34.8 | 7 | NEUTRAL | 89.7 |
| BCHMF Bachem Holding AG | $6.8B | 41.9 | 10.6 | 8.2 | 15.4 | 4.3 | 3 | NEUTRAL | 24.7 |
| AHICF Asahi Intecc Co., Ltd. | $5.7B | 30.5 | 20.0 | 27.8 | 14.6 | 21.6 | 9 | NEUTRAL | 33.4 |
| BUHPF Bumrungrad Hospital Public Company Limited | $4.8B | 21.0 | 27.3 | 37.3 | 30.3 | 1.6 | 5 | NEUTRAL | 23.7 |
| ANSLY Ansell Limited | $4.7B | 22.3 | 10.6 | 9.5 | 10.8 | 7.1 | 8 | NEUTRAL | 43.8 |
| CSMYF COSMOS Pharmaceutical Corporation | $3.2B | 15.6 | 11.7 | 9.8 | 2.9 | 9.5 | 6 | NEUTRAL | -12.2 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 15.5 | 10.0 | 11.6 | 2.2 | 46.6 | 7 | NEUTRAL | 18.3 |
| SAFLY Safilo Group S.p.A. | $1.4B | 15.4 | 12.0 | 10.0 | 8.7 | -3.4 | 7 | NEUTRAL | 40.1 |
| VREX Varex Imaging Corporation | $780M | 35.1 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | NEUTRAL | 55.0 |
| CSSPF NIOX Group Plc | $380M | 41.3 | 10.8 | 13.0 | 24.6 | 3.5 | 7 | NEUTRAL | -2.3 |
| REPL Replimune Group, Inc. | $1.1B | -4.2 | -134.3 | -1055.2 | — | — | 1 | NEUTRAL | 48.1 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| OFIX Orthofix Medical Inc. | $400M | -6.4 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | NEUTRAL | -38.6 |
| TSUSF Tsuruha Holdings Inc. | $4.2B | 17.4 | 6.2 | 12.0 | 2.8 | 16.1 | 5 | NEUTRAL | 56.8 |
| DNPUF Sumitomo Pharma Co., Ltd. | $6.4B | 6.9 | 39.1 | 10.3 | 13.1 | 14.5 | 6 | NEUTRAL | 5.6 |
| SGFEF Siegfried Holding AG | $3.9B | 19.2 | 17.0 | 9.4 | 10.8 | 3.4 | 4 | NEUTRAL | -15.8 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.3 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | NEUTRAL | 10.7 |
| AXGN AxoGen, Inc. | $2.2B | -56.1 | -18.2 | -5.6 | -2.2 | 23.6 | 4 | NEUTRAL | 110.6 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.3 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 115.1 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.6 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | NEUTRAL | 3.0 |
| JNDOF JINS HOLDINGS Inc. | $810M | 17.8 | 22.7 | 27.1 | 5.1 | 15.0 | 6 | LEAN BEAR | 51.6 |
| MCTA Charming Medical Limited Class A Ordinary Shares | $450M | — | — | — | — | — | — | LEAN BEAR | — |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | LEAN BEAR | — |
| GEDSF Gedeon Richter PLC | $4.5B | 10.7 | 16.4 | 22.0 | 29.6 | 4.8 | 7 | LEAN BEAR | 0.0 |
| GLPGF Lakefront Biotherapeutics | $2.1B | 3.8 | 20.2 | 39.4 | 17.4 | 259.3 | 5 | LEAN BEAR | -4.5 |
| OSSFF Embla Medical hf. | $1.9B | 18.0 | 10.4 | 7.7 | 10.5 | 9.9 | 7 | LEAN BEAR | -5.6 |
| STSEY Stratec SE | $1.7B | -575.0 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | LEAN BEAR | -17.8 |
| AGYTF Allergy Therapeutics plc | $760M | -4.3 | 3372.3 | -97.9 | -54.9 | 19.9 | 3 | LEAN BEAR | 66.7 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| RDNT RadNet, Inc. | $5.5B | -277.5 | -2.1 | 1.8 | 1.2 | 18.9 | 5 | LEAN BEAR | -15.5 |
| COGT Cogent Biosciences, Inc. | $5.4B | -13.9 | -109.7 | 1964.0 | — | — | 3 | LEAN BEAR | 108.3 |
| STVN Stevanato Group S.p.A. | $5.3B | 36.1 | 9.1 | 7.2 | 7.6 | 6.7 | 6 | LEAN BEAR | -28.0 |
| DFTX Definium Therapeutics, Inc. | $4.8B | -10.8 | -25.7 | 82.4 | — | — | 2 | LEAN BEAR | — |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.8 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | LEAN BEAR | -23.5 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | LEAN BEAR | 15.3 |
| RLAY Relay Therapeutics, Inc. | $4.0B | -12.0 | -36.8 | -2519.7 | -23916.3 | 23.9 | 4 | LEAN BEAR | 168.1 |
| NUTX Nutex Health, Inc. | $1.4B | 7.8 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | LEAN BEAR | 78.2 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 118.1 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| PSNL Personalis, Inc. | $1.7B | -14.7 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | LEAN BEAR | 68.0 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.3 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | LEAN BEAR | 0.0 |
| RSLBF RaySearch Laboratories AB (publ) | $510M | 31.8 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | LEAN BEAR | -35.8 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 46.0 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.6 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 67.7 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | LEAN BEAR | -5.4 |
| ALMR Alamar Biosciences, Inc. | $2.1B | — | — | — | — | — | — | LEAN BEAR | — |
| HNGZY Hangzhou Tigermed Consulting Co., Ltd | $6.9B | 597.8 | 0.5 | 1.6 | -24.2 | 12.0 | 6 | LEAN BEAR | 11.2 |
| SHJBF Shanghai Junshi Biosciences Co., Ltd. | $4.8B | -69.3 | -7.1 | -6.3 | 4.4 | 29.7 | 5 | LEAN BEAR | -20.8 |
| MCVEF Medicover AB (publ) | $4.1B | 44.6 | 16.9 | 6.8 | 3.8 | 9.4 | 7 | LEAN BEAR | 0.0 |
| MDRSF Medartis Holding AG | $1.4B | 78.9 | 5.5 | 0.7 | 3.2 | 29.6 | 6 | LEAN BEAR | 72.5 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -8.9 | -45.3 | -2390.9 | — | — | 2 | LEAN BEAR | 44.6 |
| CLDX Celldex Therapeutics, Inc. | $2.3B | -6.9 | -43.9 | -13685.9 | -334104.5 | -98.1 | 1 | LEAN BEAR | 12.3 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.9 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | LEAN BEAR | 8.9 |
| LJUIF SSY Group Limited | $1.2B | 15.2 | 6.7 | 4.6 | 13.6 | -4.4 | 5 | LEAN BEAR | 0.0 |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 64.9 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | LEAN BEAR | 0.0 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.0 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BEAR | 12.5 |
| PTKFF PT Kalbe Farma Tbk. | $2.0B | 8.9 | 15.4 | 17.6 | 9.1 | 13.2 | 5 | LEAN BEAR | -18.5 |
| BIOGY BioGaia AB (publ) | $1.3B | 32.0 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | LEAN BEAR | 9.2 |
| OMDA Omada Health | $1.2B | 284.8 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | LEAN BEAR | -25.1 |
| JXFGF Jinxin Fertility Group Limited | $730M | 26.4 | 1.9 | 1.8 | 7.8 | 1.4 | 7 | LEAN BEAR | 3.6 |
| AUNA Auna S.A. | $380M | -17.4 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | LEAN BEAR | -20.2 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| CLVSF CellaVision AB (publ) | $330M | 31.6 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| OGN Organon & Co. | $3.6B | 17.4 | 24.0 | 6.0 | 6.9 | -2.5 | 5 | LEAN BEAR | 52.4 |
| SRRK Scholar Rock Holding Corporation | $5.0B | -12.8 | -167.8 | 931.3 | — | — | 2 | LEAN BEAR | 45.5 |
| ELVN Enliven Therapeutics, Inc. | $3.0B | -26.5 | -15.3 | -6535.0 | — | — | 3 | LEAN BEAR | 101.9 |
| UFPT UFP Technologies, Inc. | $2.3B | 31.4 | 17.1 | 13.3 | 12.0 | 7.3 | 7 | LEAN BEAR | 45.5 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BEAR | -19.7 |
| GALNF Galenica AG | $5.0B | 27.6 | 11.2 | 6.8 | 3.1 | 6.2 | 4 | BEARISH | 32.2 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| MDRX Veradigm Inc. | $830M | -7.1 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | BEARISH | 0.0 |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | BEARISH | -17.0 |
| HSIC Henry Schein, Inc. | $9.5B | 24.3 | 12.2 | 8.7 | 2.7 | 6.5 | 7 | BEARISH | 32.9 |
| INDV Indivior Pharmaceuticals Inc | $4.3B | 12.1 | -152.4 | 528.3 | 35.6 | 13.5 | 4 | BEARISH | 36.7 |
| NEO NeoGenomics, Inc. | $2.2B | -43.6 | -6.3 | -4.8 | 1.1 | 11.2 | 5 | BEARISH | 59.7 |
| ABSI Absci Corporation | $1.6B | -13.4 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BEARISH | 120.8 |
| SNBIF SanBio Company Limited | $1.3B | -19.5 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| CVSGF CVS Group plc | $1.1B | 52.6 | 5.9 | 7.3 | 2.7 | -22.7 | 6 | BEARISH | 0.7 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.6 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BEARISH | -56.5 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.4 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BEARISH | -31.8 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 9.0 | 14.3 | 13.4 | 11.4 | 22.0 | 4 | BEARISH | -22.7 |
| BOIRF Boiron S.A. | $550M | 12.7 | 7.2 | 7.8 | 2.0 | 97.0 | 5 | BEARISH | 10.5 |
| IMPZY Implanet S.A. | $230M | -5.1 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| RYTM Rhythm Pharmaceuticals, Inc. | $6.2B | -29.5 | -200.0 | 144.2 | -69.2 | 53.5 | 4 | BEARISH | -18.0 |
| ACAD Acadia Pharmaceuticals Inc. | $3.4B | 9.0 | 35.7 | 63.9 | 10.2 | 11.8 | 5 | BEARISH | -9.2 |
| PANHF Ping An Healthcare and Technology Company Limited | $2.1B | 20.7 | 4.6 | 5.6 | 8.8 | 2.9 | 6 | BEARISH | -61.7 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.4 | -46.6 | 137.5 | — | — | 3 | BEARISH | 77.0 |
| RYHTY Ryman Healthcare Limited | $1.0B | -10.8 | -4.2 | -0.3 | -30.8 | 10.6 | 7 | BEARISH | -23.4 |
| ANGO AngioDynamics, Inc. | $520M | -15.4 | -19.2 | -20.5 | -8.8 | 8.2 | 5 | BEARISH | 1.4 |
| CLOV Clover Health Investments, Corp. | $2.4B | -114.2 | -5.1 | -8.3 | 3.8 | 54.0 | 4 | BEARISH | 42.5 |
| STLN Starling Oncology, Inc. | $670M | — | — | — | — | — | — | BEARISH | — |
| MEOBF Mesoblast Limited | $2.0B | -29.4 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -9.0 |
| EWTX Edgewise Therapeutics, Inc. | $4.2B | -21.4 | -38.0 | 1912.5 | — | — | 1 | BEARISH | 159.4 |
| ADPT Adaptive Biotechnologies Corporation | $4.1B | -68.5 | -39.6 | -14.1 | -55.6 | 50.1 | 5 | BEARISH | 53.1 |
| RGC Regencell Bioscience Holdings Limited | $3.8B | -311.9 | -128.5 | 1692.4 | — | — | 3 | BEARISH | -57.8 |
| CLCGY Clicks Group Limited | $3.1B | 15.8 | 47.7 | 39.1 | 6.5 | 6.3 | 6 | BEARISH | -37.6 |
| PHVS Pharvaris N.V. | $2.2B | -10.6 | -70.7 | 860.9 | — | — | 4 | BEARISH | 37.1 |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.8 | 4.5 | 6.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| OCS Oculis Holding AG | $490M | -4.7 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -62.7 |
| ALVOW Alvotech | $3.9B | -8.1 | 98.5 | 3.3 | -63.2 | -12.2 | 0 | BEARISH | -84.6 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | BEARISH | — |
| PPTDF PeptiDream Inc. | $870M | -38.0 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| SLS SELLAS Life Sciences Group, Inc. | $2.3B | -57.2 | -39.6 | 55646.0 | — | — | 4 | BEARISH | 493.7 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.0 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BEARISH | -17.9 |
| CSPHF CStone Pharmaceuticals | $1.4B | -14.4 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 614.5 |
| SMSZF SMS Co., Ltd. | $700M | -14.9 | -40.8 | 31.1 | 18.4 | 6.9 | 6 | BEARISH | 0.0 |
| ZRSEF DocMorris AG | $520M | -10.1 | -30.1 | -29.3 | -8.9 | 11.0 | 2 | BEARISH | 0.0 |
| NPCE NeuroPace, Inc. | $440M | -23.0 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | BEARISH | 23.1 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 37.8 |
| CTEV Claritev Corporation | $400M | -1.4 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | BEARISH | -67.4 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | BEARISH | -18.0 |
| TNGX Tango Therapeutics, Inc. | $3.9B | -27.3 | -21.3 | -253.2 | — | 121.5 | 3 | BEARISH | 194.8 |
| NHNKY Nihon Kohden Corporation | $3.1B | 19.1 | 7.8 | 7.9 | -1.6 | 2.6 | 9 | BEARISH | -22.6 |
| GRDN Guardian Pharmacy Services, Inc. | $2.5B | 37.6 | 31.7 | 33.2 | 6.2 | 10.3 | 7 | BEARISH | 39.9 |
| EXETF Extendicare Inc. | $1.9B | 20.3 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 74.0 |
| NPRRF Nipro Corporation | $1.4B | — | — | — | — | — | — | BEARISH | 5.8 |
| IMNM Immunome, Inc. | $2.1B | -7.4 | -64.0 | -2208.4 | — | -100.0 | 4 | BEARISH | 11.4 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | -3.3 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | BEARISH | 88.1 |
| CLHLF COLTENE Holding AG | $330M | 19.7 | 16.1 | 12.5 | 3.6 | -2.5 | 5 | BEARISH | -8.4 |
| SMTI Sanara MedTech Inc. | $300M | -8.9 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | BEARISH | 9.8 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | BEARISH | — |
| PCVX Vaxcyte, Inc. | $9.5B | -8.0 | -36.5 | -66.4 | — | — | 0 | BEARISH | 44.2 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 46.0 |
| BDULF Bangkok Dusit Medical Services Public Company Limited | $9.7B | 20.7 | 15.0 | 12.4 | 12.1 | 1.3 | 4 | BEARISH | -3.2 |
| XENE Xenon Pharmaceuticals Inc. | $3.4B | -7.6 | -43.6 | -109.7 | — | -100.0 | 3 | BEARISH | -13.2 |
| CELC Celcuity Inc. | $3.2B | -16.0 | -1433.7 | 1325.2 | — | — | 3 | BEARISH | -6.8 |
| DYN Dyne Therapeutics, Inc. | $2.9B | -5.1 | -81.6 | 240.4 | — | — | 2 | BEARISH | -4.7 |
| ALHC Alignment Healthcare, Inc. | $1.7B | 40.0 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -54.4 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -18.8 |
| ARVN Arvinas, Inc. | $470M | 39.1 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -20.2 |
| PRTA Prothena Corporation plc | $420M | -10.5 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -13.8 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BEARISH | 25.2 |
| RADLY Raia Drogasil S.A. | $7.2B | 20.7 | 19.4 | 16.9 | 3.8 | 10.9 | 7 | BEARISH | -21.9 |
| KNSA Kiniksa Pharmaceuticals International, plc | $6.0B | 63.0 | 14.0 | 51.6 | 10.4 | 58.9 | 7 | BEARISH | 88.2 |
| SHPMY Shanghai Pharmaceuticals Holding Co., Ltd | $5.1B | 12.8 | 6.2 | 6.5 | 2.9 | 4.1 | 5 | BEARISH | -16.3 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.1 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -55.2 |
| WHTCF WELL Health Technologies Corp. | $770M | 165.0 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | BEARISH | -17.4 |
| FLGT Fulgent Genetics, Inc. | $550M | -7.3 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | BEARISH | -14.4 |
| EOLS Evolus, Inc. | $460M | -14.2 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BEARISH | 6.2 |
| EDIT Editas Medicine, Inc. | $370M | -3.4 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BEARISH | -34.2 |
| TTRX Turn Therapeutics Inc. | $310M | -36.1 | -952.4 | 115.0 | — | — | 2 | BEARISH | 114.3 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.3 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -24.4 |
| GNNSF Genscript Biotech Corporation | $9.6B | -14.1 | -15.4 | 2.9 | -32.0 | 53.1 | 4 | BEARISH | 97.7 |
| INMD InMode Ltd. | $800M | 10.9 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -11.4 |
| TKNO Alpha Teknova, Inc. | $340M | -22.4 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | BEARISH | 14.4 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| VBIZF Viva Biotech Holdings | $400M | 13.1 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| MIRM Mirum Pharmaceuticals, Inc. | $5.2B | -5.9 | -703.0 | -27.3 | -38.1 | 44.0 | 3 | BEARISH | 20.0 |
| SUPN Supernus Pharmaceuticals, Inc. | $2.4B | -21.2 | -10.5 | -12.6 | -26.6 | 24.9 | 3 | BEARISH | -21.6 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -29.8 |
| HROW Harrow Health, Inc. | $1.1B | -29.5 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -25.9 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.1 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -15.1 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | BEARISH | 6.0 |
| TWST Twist Bioscience Corporation | $9.2B | -71.7 | -29.6 | -29.2 | -29.6 | 19.2 | 2 | BEARISH | 356.3 |
| LNTH Lantheus Holdings, Inc. | $6.5B | 23.8 | 22.2 | 17.1 | 19.3 | 2.3 | 5 | BEARISH | 76.8 |
| ABCL AbCellera Biologics Inc. | $3.8B | -23.5 | -17.3 | -36.2 | -1368.6 | 101.3 | 4 | BEARISH | 111.6 |
| NHC National HealthCare Corporation | $3.7B | 23.5 | 13.1 | 12.6 | 9.9 | 6.9 | 8 | BEARISH | 83.8 |
| CAMRF Camurus AB | $3.7B | 58.2 | 15.8 | 89.3 | 34.3 | -0.2 | 6 | BEARISH | -10.3 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.3 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 8.8 |
| IRWD Ironwood Pharmaceuticals, Inc. | $570M | 4.4 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 114.7 |
| RMYHY Ramsay Health Care Limited | $9.2B | 40.8 | 6.6 | 4.2 | 1.8 | 4.2 | 7 | BEARISH | 85.2 |
| DNTH Dianthus Therapeutics, Inc. | $4.3B | -610.5 | -4.1 | -60.1 | -6598.6 | -60.8 | 3 | BEARISH | 138.4 |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | -7.6 |
| HYPMY Hypera S.A. | $3.8B | 7.9 | 13.2 | 12.8 | 21.0 | 31.8 | 8 | BEARISH | -7.7 |
| RCUS Arcus Biosciences, Inc. | $2.3B | -4.6 | -89.2 | 309.6 | -222.0 | -55.3 | 0 | BEARISH | 5.8 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 2.0 |
| PRAX Praxis Precision Medicines, Inc. | $7.1B | -20.8 | -38.9 | -51.2 | — | -100.0 | 4 | BEARISH | 50.2 |
| CMOPF Cosmo N.V. | $1.1B | -158.0 | -1.2 | -2.9 | -9.5 | -43.8 | 1 | BEARISH | -23.8 |
| BEAM Beam Therapeutics Inc. | $2.5B | -30.2 | -8.1 | -184.5 | -25036.3 | 158.9 | 4 | BEARISH | -15.6 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BEARISH | -34.0 |
| LTGO Latigo Biotherapeutics Inc. | $900M | — | — | — | — | — | — | BEARISH | — |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.2 |
| MTLZF Metall Zug AG | $680M | -34.8 | -2.8 | -1.4 | -5.6 | -0.3 | 6 | BEARISH | 0.0 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | BEARISH | -70.0 |
| ELMD Electromed, Inc. | $220M | 19.3 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 8.1 |
| IRMD IRadimed Corporation | $1.1B | 46.0 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 9.4 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.6 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BEARISH | 46.0 |
| ARWR Arrowhead Pharmaceuticals, Inc. | $8.2B | -26.6 | -64.8 | 65.7 | -258.2 | 12.2 | 4 | BEARISH | 57.9 |
| IMVT Immunovant, Inc. | $5.9B | -10.2 | -80.1 | 707.5 | -2159.6 | — | 2 | BEARISH | 50.3 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.6 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 17.5 |
| QURE uniQure N.V. | $1.6B | -5.9 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -63.5 |
| MGTX MeiraGTx Holdings plc | $880M | 12.3 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 4.9 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.9 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| DNLI Denali Therapeutics Inc. | $2.9B | -6.7 | -54.9 | -281.7 | -3539.2 | — | 3 | BEARISH | 17.5 |
| MNKD MannKind Corporation | $1.0B | -23.4 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -41.2 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| TXG 10x Genomics, Inc. | $9.3B | -132.5 | -9.4 | -19.8 | -11.9 | -4.3 | 5 | BEARISH | 446.1 |
| BLTE Belite Bio, Inc | $5.9B | -52.9 | -20.8 | -11.5 | — | — | 3 | BEARISH | 55.4 |
| CGON CG Oncology Inc. | $5.5B | -23.5 | -26.4 | -2066.1 | -6832.8 | 1030.3 | 3 | BEARISH | 46.6 |
| RTEZ Rest Ez Inc. | $4.2B | — | — | — | — | — | — | BEARISH | 0.0 |
| AMLX Amylyx Pharmaceuticals, Inc. | $3.4B | -19.9 | -74.7 | 2020.5 | — | 100.0 | 5 | BEARISH | 89.3 |
| INCPF InnoCare Pharma Limited | $2.4B | 18.7 | 12.6 | 45.8 | 23.1 | 108.5 | 4 | BEARISH | -50.9 |
| DMPHF Dermapharm Holding SE | $2.4B | 13.9 | 25.6 | 13.0 | 8.1 | 0.5 | 5 | BEARISH | 20.6 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 9.6 |
| BFLY Butterfly Network, Inc. | $1.8B | -25.4 | -35.5 | -74.8 | -39.6 | 28.1 | 4 | BEARISH | 199.6 |
| NVCR Novocure Ltd | $1.7B | -11.2 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 3.5 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.9 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 77.1 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -11.2 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 212.4 |
| OMER Omeros Corporation | $1.2B | 9.1 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 112.9 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.4 | -845.0 | 24.6 | — | — | 2 | BEARISH | 32.9 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.0 | -214.6 | 174.4 | — | — | 1 | BEARISH | 207.7 |
| MDXG MiMedx Group, Inc. | $570M | 96.6 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.0 |
| STTK Shattuck Labs, Inc. | $550M | -11.4 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 199.5 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | -0.2 |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -57.6 |
| VRNO Verano Holdings Corp | $370M | -1.4 | -4.5 | 1.5 | -6.0 | — | 3 | BEARISH | — |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.5 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BEARISH | 13.3 |
| EBS Emergent BioSolutions Inc. | $320M | -1.9 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | BEARISH | -34.4 |
| DMTRF 3-D Matrix, Ltd. | $310M | 11.9 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| YPHDF Ypsomed Holding AG | $5.7B | 23.8 | 31.1 | 17.4 | 22.5 | -2.3 | 8 | BEARISH | -8.1 |
| VRBCF Virbac S.A. | $3.2B | 18.8 | 13.6 | 12.7 | 11.4 | 3.9 | 5 | BEARISH | 10.8 |
| MEDGF Medacta Group S.A. | $2.7B | 33.1 | 17.1 | 9.8 | 11.4 | 8.9 | 4 | BEARISH | 63.9 |
| ORPEF Emeis | $2.3B | -4.5 | -19.0 | 3.2 | -5.4 | 40.2 | 5 | BEARISH | 0.0 |
| SNDA Sonida Senior Living, Inc. | $1.6B | -5.3 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 28.4 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 109.0 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 170.6 |
| MEDOF Medios AG | $1.3B | 23.5 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 44.5 |
| CSBTF Kuros Biosciences AG | $950M | 109.9 | 9.6 | 9.2 | 4.8 | 29.1 | 4 | BEARISH | -43.1 |
| IART Integra LifeSciences Holdings Corporation | $930M | 70.5 | 1.2 | 13.4 | 3.6 | 0.8 | 6 | BEARISH | -23.8 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.3 | -49.2 | -201.4 | — | — | 3 | BEARISH | 97.7 |
| AKTS Aktis Oncology, Inc. | $850M | -15.8 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 245681.2 |
| DSGN Design Therapeutics, Inc. | $640M | -9.1 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 81.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 5.2 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 18.9 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 537.4 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -13.2 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 30.4 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | 27.3 |
| CYTK Cytokinetics, Incorporated | $8.5B | -8.5 | 329.8 | 811.2 | -622.8 | -17.2 | 2 | BEARISH | 5.6 |
| MMED MiniMed Group, Inc. | $5.2B | — | — | — | — | — | — | BEARISH | — |
| VERA Vera Therapeutics, Inc. | $2.0B | -5.1 | -91.8 | 2030.6 | — | — | 1 | BEARISH | 0.3 |
| HBMHF HBM Holdings Limited | $1.3B | 12.5 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.0 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | -0.2 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -41.1 |
| EBOSY EBOS Group Limited | $1.0B | 15.3 | 5.0 | 4.4 | 1.7 | -8.1 | 6 | BEARISH | -47.5 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.8 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | 1.0 |
| ALMS Alumis Inc. | $880M | -1.8 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 41.2 |
| XVIPY Xvivo Perfusion AB (publ) | $690M | 49.4 | 5.9 | 4.6 | 17.7 | 17.5 | 6 | BEARISH | — |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| SWDCF Swedencare AB (publ) | $370M | 35.2 | 1.2 | 1.7 | 3.9 | 1.4 | 7 | BEARISH | -35.8 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 46.1 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -38.6 |
| CORT Corcept Therapeutics Incorporated | $9.3B | 168.0 | 8.1 | 3.1 | 16.5 | 16.0 | 6 | BEARISH | 19.4 |
| KRYS Krystal Biotech, Inc. | $9.2B | 38.6 | 20.1 | 40.4 | 45.9 | 22.6 | 7 | BEARISH | 68.2 |
| HIMS Hims & Hers Health, Inc. | $6.2B | -45.7 | -32.0 | -7.1 | -11.5 | 28.0 | 4 | BEARISH | -43.1 |
| CRSP CRISPR Therapeutics AG | $4.8B | -10.7 | -26.1 | -253.2 | -895.3 | -62.7 | 3 | BEARISH | -27.1 |
| IDYA IDEAYA Biosciences, Inc. | $3.4B | -17.4 | -16.2 | -42.9 | -1269.6 | 3244.7 | 4 | BEARISH | 15.7 |
| TARS Tarsus Pharmaceuticals, Inc. | $3.2B | -65.1 | -13.7 | 268.1 | -10.7 | 105.2 | 5 | BEARISH | 2.5 |
| TLX Telix Pharmaceuticals Limited | $3.1B | 92.5 | 8.6 | -1.0 | 8.0 | 10.5 | 4 | BEARISH | -17.4 |
| MBX MBX Biosciences, Inc. Common Stock | $2.3B | -22.1 | -33.2 | 1634.0 | — | — | 2 | BEARISH | 211.8 |
| PGEN Precigen, Inc. | $2.2B | -5.4 | -4640.4 | -30.1 | 36.5 | 1875.0 | 5 | BEARISH | 42.1 |
| WGS GeneDx Holdings Corp. | $1.7B | -17.2 | -40.8 | -17.2 | -15.5 | 25.4 | 4 | BEARISH | -51.0 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -27.9 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 5.7 |
| HELP Helus Pharma Inc. | $630M | -2.6 | -56.3 | -143.0 | — | — | 2 | BEARISH | — |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.3 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 10.3 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -10.8 |
| AQST Aquestive Therapeutics, Inc. | $500M | -6.2 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -43.5 |
| DCTH Delcath Systems, Inc. | $500M | 1344.2 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 39.8 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -6.9 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 20.6 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -2.9 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -29.4 |
| IBRX ImmunityBio, Inc. | $8.7B | -8.8 | 122.7 | 33.7 | -449.6 | 192.9 | 4 | BEARISH | 226.8 |
| TVTX Travere Therapeutics, Inc. | $4.7B | -112.6 | -151.8 | -21.0 | -20.5 | 77.1 | 6 | BEARISH | 77.5 |
| HAWPY Haw Par Corporation Limited | $3.0B | 12.3 | 5.2 | 1.6 | 93.0 | -12.8 | 4 | BEARISH | -20.4 |
| CHSYF China Medical System Holdings Limited | $2.7B | 13.6 | 8.6 | 9.0 | 21.9 | 9.2 | 4 | BEARISH | -17.8 |
| BRCTF BioArctic AB | $2.6B | 263.7 | 5.2 | 77.4 | -4.5 | -46.1 | 3 | BEARISH | -8.6 |
| HRMY Harmony Biosciences Holdings, Inc. | $2.1B | 12.0 | 20.5 | 35.7 | 28.9 | 24.3 | 5 | BEARISH | 24.4 |
| ARSUF Fagron N.V. | $2.0B | 18.9 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -62.5 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -9.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.2 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 96.4 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.3 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | 2.7 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 12.4 |
| ELEAF EL.En. S.p.A. | $1.4B | 13.7 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 37.9 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 206.2 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IMMX Immix Biopharma, Inc. | $680M | -9.3 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 135.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 46.7 |
| CLYM Climb Bio, Inc. | $590M | -11.6 | -27.1 | -88.6 | — | — | 2 | BEARISH | 342.7 |
| AVR Anteris Technologies Global Corp. | $570M | -2.2 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 3.4 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| SENS Senseonics Holdings, Inc. | $400M | -3.7 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BEARISH | 1.8 |
| VREOF Vireo Growth Inc. | $310M | -4.1 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| IONS Ionis Pharmaceuticals, Inc. | $7.1B | -12.7 | -105.4 | -58.5 | -42.8 | -7.4 | 3 | BEARISH | -39.3 |
| REGMF RemeGen Co., Ltd. | $5.6B | 9.1 | 108.3 | 139.6 | 83.4 | 283.6 | 7 | BEARISH | -16.4 |
| PTCT PTC Therapeutics, Inc. | $5.1B | -126.1 | 20.6 | -5.4 | 23.2 | -42.8 | 2 | BEARISH | -8.6 |
| LABFF Laboratorios Farmaceuticos Rovi, S.A. | $3.4B | 17.1 | 29.3 | 19.6 | 39.1 | 3.3 | 6 | BEARISH | -25.9 |
| AMFPF Amplifon S.p.A. | $3.0B | 42.8 | 5.7 | 7.2 | 6.4 | -0.2 | 5 | BEARISH | -36.3 |
| PBLS Parabilis Medicines, Inc. | $3.0B | — | — | — | — | — | — | BEARISH | — |
| BKD Brookdale Senior Living Inc. | $2.4B | -16.5 | -362.1 | 10.3 | 3.2 | -2.3 | 6 | BEARISH | 11.9 |
| NAMS NewAmsterdam Pharma Company N.V. | $2.3B | -9.4 | -36.8 | 8216.2 | -1732.9 | -88.9 | 2 | BEARISH | -46.2 |
| ADDLF AddLife AB (publ) | $1.9B | 34.5 | 11.3 | 7.0 | 4.9 | 1.1 | 4 | BEARISH | -62.5 |
| VIMGF Vimian Group AB (publ) | $1.5B | 48.7 | 5.4 | 6.4 | 7.4 | 8.9 | 7 | BEARISH | -8.0 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | -9.9 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.6 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| TTALF Terveystalo Oyj | $910M | 13.3 | 10.3 | 6.3 | 2.1 | -8.7 | 4 | BEARISH | -44.5 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.8 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| ARDX Ardelyx, Inc. | $770M | -13.2 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.7 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -5.7 |
| SANA Sana Biotechnology, Inc. | $700M | -3.2 | -152.9 | -242.3 | — | — | 3 | BEARISH | -57.8 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $660M | 10.8 | 4.1 | 12.2 | 8.2 | -18.2 | 6 | BEARISH | -43.0 |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -54.5 |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -26.2 |
| CRWRF Craneware plc | $620M | 25.9 | 6.0 | 6.8 | 9.7 | 4.2 | 7 | BEARISH | -43.9 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 21.3 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -18.2 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.2 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -32.4 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 16.9 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| BWAY BrainsWay Ltd. | $440M | 47.1 | 13.0 | 31.1 | 15.8 | 32.3 | 5 | BEARISH | 34.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.4 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| TLRY Tilray Brands, Inc. | $310M | -2.0 | -8.8 | -3.4 | -16.8 | -16.9 | 3 | BEARISH | -81.6 |
| AXSM Axsome Therapeutics, Inc. | $7.6B | -37.9 | -245.1 | 859.1 | -23.5 | 56.9 | 5 | BEARISH | 13.4 |
| SFOSF Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | $5.8B | 17.8 | 10.7 | 6.3 | 8.4 | 53.9 | 7 | BEARISH | -34.2 |
| TRSBF 3SBio Inc. | $4.3B | 3.4 | 37.1 | 80.3 | 25.3 | 93.8 | 7 | BEARISH | -48.7 |
| VKTX Viking Therapeutics, Inc. | $3.1B | -5.3 | -88.9 | 495.6 | — | — | 1 | BEARISH | -28.6 |
| TMDX TransMedics Group, Inc. | $2.5B | 15.8 | 36.3 | 18.7 | 7.7 | 25.8 | 3 | BEARISH | -45.2 |
| ZLDPF Zealand Pharma A/S | $2.4B | 5.8 | 16.3 | 57.2 | 87.2 | -49.2 | 3 | BEARISH | -54.1 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 20.5 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -4.9 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -49.6 |
| FDMDF 4DMedical Limited | $1.6B | -9.2 | -174.5 | 43.4 | -1194.8 | 20.5 | 3 | BEARISH | 132.8 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -43.4 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.8 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -17.0 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -20.6 |
| MCRPF MicroPort Scientific Corp. | $1.1B | 31.2 | 6.1 | -1.7 | 21.3 | -3.5 | 5 | BEARISH | -64.8 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 103.0 | 7.3 | 6.9 | -5.7 | 103.7 | 4 | BEARISH | -14.3 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 9.7 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| ATTO Attovia Therapeutics, Inc. | $630M | -15.3 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 226.6 |
| NNCSF Nanosonics Limited | $620M | 53.0 | 8.3 | 15.6 | 8.1 | 2.4 | 4 | BEARISH | -39.9 |
| EVOTF Evotec SE | $590M | -2.6 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | BEARISH | -54.3 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -57.4 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -56.4 |
| SSII SS Innovations International, Inc. | $450M | -39.0 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -74.4 |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -47.7 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.9 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 0.0 |
| CALZF PolyNovo Limited | $430M | 82.1 | 8.4 | 9.3 | 10.0 | 12.8 | 7 | BEARISH | -34.2 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -47.0 |
| ASMB Assembly Biosciences, Inc. | $400M | 37.0 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -28.5 |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 14.7 |
| NIKA Nika Pharmaceuticals Inc. | $370M | -4711.6 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 8.5 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -62.2 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -6.4 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -17.7 |
| CLPT ClearPoint Neuro, Inc. | $280M | -8.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -64.2 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
KIDS vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F